Clearance and bioavailability study through arterio-venous drug concentrations relationship.

[1]  P. Fagiolino,et al.  Is saliva suitable as a biological fluid in relative bioavailability studies? Analysis of its performance in a 4 × 2 replicate crossover design , 2011, European Journal of Drug Metabolism and Pharmacokinetics.

[2]  A. Scaramelli,et al.  Influence of Efflux Transporters on Drug Metabolism , 2011, Clinical pharmacokinetics.

[3]  S. Kaasa,et al.  Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference? , 2008, European Journal of Clinical Pharmacology.

[4]  M. Vázquez,et al.  The Influence of Cardiovascular Physiology on Dose/Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Relationships , 2006, Clinical pharmacokinetics.

[5]  G. Hoizey,et al.  Arterio-venous ethanol levels in blood and plasma after intravenous injection in rabbits. , 1998, Alcohol.

[6]  N. Benowitz,et al.  Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine , 1997, Clinical pharmacology and therapeutics.

[7]  M. Vázquez,et al.  Post-prandial reabsorption of paracetamol , 1994 .

[8]  W. L. Chiou,et al.  Determination of the steady‐state volume of distribution using arterial and venous plasma data from constant infusion studies with procainamide , 1982, The Journal of pharmacy and pharmacology.

[9]  J. Posti.  Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications. , 1982, Pharmaceutica acta Helvetiae.